Effects of a new anorectic drug (PM 170) on development of gold thioglucose-induced obesity in mice.
Gold thioglucose (GTG)-injected mice and lean mice were treated for 16 days with PM 170. The body weight and body fat were significantly increased by GTG injection and these increases in the GTG-obese group were reduced by PM 170. PM 170 also reduced food intake (16%), total body triacylglycerol (51%) and total body cholesterol (36%). Basal lipolysis of white adipose tissue, as measured by glycerol release, was stimulated by 150%. Compared to GTG-PM 170 mice, body weight gain was 2 times higher in GTG-pair-fed mice. Body fat and total body lipid content remained elevated.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001067:Appetite Depressants / Q000627:therapeutic use*; D006051:Aurothioglucose; D001835:Body Weight / Q000187:drug effects; D004247:DNA / Q000378:metabolism; D004435:Eating / Q000187:drug effects; D005260:Female; D006046:Gold; D008099:Liver / Q000187:drug effects; D051379:Mice; D009765:Obesity / Q000139:chemically induced / Q000517:prevention & control*; D009929:Organ Size / Q000187:drug effects; D010880:Piperidines / Q000627:therapeutic use*
D001067:Appetite Depressants; D010880:Piperidines; D006051:Aurothioglucose; D006046:Gold; C048315:PM 170; D004247:DNA